ANI Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ANIP Nasdaq 2830 www.anipharmaceuticals.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ANI Pharmaceuticals, Inc.

Did FDA Approval of Generic Everolimus Suspension Just Shift ANI Pharmaceuticals' (ANIP) Investment Narrative? - Oct 7th, 2026 4:13 pm
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Turn Down - Oct 6th, 2026 3:44 am
1 Small-Cap Stock for Long-Term Investors and 2 We Ignore - Oct 1st, 2026 6:13 am
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting - Sep 30th, 2026 4:55 am
3 Profitable Stocks Worth Investigating - Sep 29th, 2026 4:16 am
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - Sep 28th, 2026 8:41 am
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know - Sep 23rd, 2026 3:38 pm
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension - Sep 23rd, 2026 4:55 am
2 Cash-Producing Stocks to Target This Week and 1 We Avoid - Sep 18th, 2026 5:36 am
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board - Sep 4th, 2026 4:14 pm
2 Value Stocks on Our Watchlist and 1 We Find Risky - Sep 1st, 2026 4:50 am
2 Reasons to Like ANIP (and 1 Not So Much) - Aug 27th, 2026 5:45 pm
1 Russell 2000 Stock to Target This Week and 2 We Brush Off - Aug 24th, 2026 9:13 am
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors - Aug 24th, 2026 4:55 am
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Aug 16th, 2026 3:09 am
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks - Aug 15th, 2026 11:49 am
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? - Aug 14th, 2026 11:15 am
ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth - Aug 14th, 2026 11:12 am